161
Views
0
CrossRef citations to date
0
Altmetric
Research Article

MicroRNA-144 silencing attenuates intimal hyperplasia by directly targeting PTEN

, &
Pages 678-686 | Received 18 Apr 2022, Accepted 07 Sep 2022, Published online: 18 Sep 2022

References

  • Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84(3):767–801.doi:10.1152/physrev.00041.2003.
  • Rzucidlo EM. Signaling pathways regulating vascular smooth muscle cell differentiation. Vascular. 2009;Suppl 17(1_suppl):S15–20.doi:10.2310/6670.2008.00089.
  • ER OB, Ma X, Simard T, Pourdjabbar A, Hibbert B. Pathogenesis of neointima formation following vascular injury. Cardiovasc Hematol Disord Drug Targets. 2011;11(1):30–39.doi:10.2174/187152911795945169.
  • Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.doi:10.1016/S0092-8674(04)00045-5.
  • Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–33.doi:10.1016/j.cell.2009.01.002.
  • Chen B, Luo L, Wei X, Gong D, Jin L. Altered plasma miR-144 as a novel biomarker for coronary artery disease. Ann Clin Lab Sci. 2018;48(4):440–45.
  • Fu W, Liu Z, Zhang J, Shi Y, Zhao R, Zhao H. Effect of microRNA-144-5p on the proliferation, invasion and migration of human umbilical vein endothelial cells by targeting SMAD1. Exp Ther Med. 2020;19(1):165–71.doi:10.3892/etm.2019.8194.
  • Hu YW, Hu YR, Zhao JY, Li SF, Ma X, Wu SG, Lu JB, Qiu YR, Sha YH, Wang YC, et al. An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS One. 2014;9(4):e94997.doi:10.1371/journal.pone.0094997.
  • Cheng J, Cheng A, Clifford BL, Wu X, Hedin U, Maegdefessel L, Pamir N, Sallam T, Tarling EJ, de Aguiar Vallim TQ. MicroRNA-144 silencing protects against atherosclerosis in male, but not female mice. Arterioscler Thromb Vasc Biol. 2020;40(2):412–25.doi:10.1161/ATVBAHA.119.313633.
  • He Q, Wang F, Honda T, Greis KD, Redington AN. Ablation of miR-144 increases vimentin expression and atherosclerotic plaque formation. Sci Rep. 2020;10(1):6127.doi:10.1038/s41598-020-63335-7.
  • Shukla GC, Singh J, Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol. 2011;3(3):83–92.
  • Velle-Forbord T, Eidlaug M, Debik J, Saether JC, Follestad T, Nauman J, Gigante B, Rosjo H, Omland T, Langaas M, et al. Circulating microRNAs as predictive biomarkers of myocardial infarction: evidence from the HUNT study. Atherosclerosis. 2019;289:1–7.doi:10.1016/j.atherosclerosis.2019.07.024.
  • Wang X, Zheng Y, Ma Y, Du L, Chu F, Gu H, Dahlgren RA, Li Y, Wang H. Lipid metabolism disorder induced by up-regulation of miR-125b and miR-144 following beta-diketone antibiotic exposure to F0-zebrafish (Danio rerio). Ecotoxicol Environ Saf. 2018;164:243–52.doi:10.1016/j.ecoenv.2018.08.027.
  • Dong X, Yu LG, Sun R, Cheng YN, Cao H, Yang KM, Dong YN, Wu Y, Guo XL. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells. J Cell Biochem. 2013;114(1):174–82.doi:10.1002/jcb.24315.
  • Huang J, Kontos CD. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol. 2002;22(5):745–51.doi:10.1161/01.ATV.0000016358.05294.8D.
  • Hata JA, Petrofski JA, Schroder JN, Williams ML, Timberlake SH, Pippen A, Corwin MT, Solan AK, Jakoi A, Gehrig TR, et al. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts. J Thorac Cardiovasc Surg. 2005;129(6):1405–13.doi:10.1016/j.jtcvs.2004.11.048.
  • Jia G, Mitra AK, Gangahar DM, Agrawal DK. Regulation of cell cycle entry by PTEN in smooth muscle cell proliferation of human coronary artery bypass conduits. J Cell Mol Med. 2009;13(3):547–54.doi:10.1111/j.1582-4934.2008.00384.x.
  • Huang J, Niu X-L, Pippen AM, Annex BH, Kontos CD. Adenovirus-mediated intraarterial delivery of PTEN inhibits neointimal hyperplasia. Arterioscler Thromb Vasc Biol. 2005;25(2):354–58.doi:10.1161/01.ATV.0000151619.54108.a5.
  • Nemenoff RA, Simpson PA, Furgeson SB, Kaplan-Albuquerque N, Crossno J, Garl PJ, Cooper J, Weiser-Evans MCM. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell–derived factor-1α. Circ Res. 2008;102(9):1036–45.doi:10.1161/CIRCRESAHA.107.169896.
  • Hu C, Liu S, Sun Y, Shi G, Li Y. Effect of recombinant hPTEN gene expression on PDGF induced VSMC proliferation. Cell Biochem Biophys. 2014;70(2):1185–90.doi:10.1007/s12013-014-0039-9.
  • Moulton KS, Li M, Strand K, Burgett S, McClatchey P, Tucker R, Furgeson SB, Lu S, Kirkpatrick B, Cleveland JC, et al. PTEN deficiency promotes pathological vascular remodeling of human coronary arteries. JCI Insight. 2018;3(4): e97228.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.